On Wednesday, Shares of Sunedison Inc (NYSE:SUNE), gained 11.85% to $9.72. The stock attained the volume of 55.09 million shares.
The year-to-date (YTD) performance reflected a -50.18% below last year. During the past month the stock loses -24.88%, bringing three-month performance to -66.74% and six-month performance to -62.67%. The stock holds the market capitalization of 3.06B, as the alternative energy firm is hoping to win back investors with plans to improve its business strategy, the Wall Street Journal reports.
This comes after the Maryland Heights, MO-based company said on Tuesday that it will lay off 1,000 employees from its workforce.
Additionally, the company said it will stop selling solar and wind farms to its own associated companies, the Journal noted.
“We de-emphasized countries, merged divisions and walked away from things that didn’t make sense in the current dislocation in the market,” CEO Ahmad Chatilla stated.
SunEdison, Inc. develops, manufactures, and sells silicon wafers to the semiconductor industry. The company operates through three segments: Solar Energy, TerraForm Power, and Semiconductor Materials.
Shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), declined -1.94% to $0.0912, during its last trading session. The share price of this stock traded recently in a range of $0.09 to $0.09. The company now has a market value of $16.72 million.
For this company, beta value at 2.42 represents it is more volatile to the shift in the market. If we take a look on its volatility, 11.15% was seen in a week and for the month it was 23.75%.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health. The companys product pipeline comprises MACRILEN, which accomplished the Phase 2 trial for use in the diagnosis of adult growth hormone deficiency; and zoptarelin doxorubicin, which is in Phase 3 clinical study zoptarelin doxorubicin in endometrial cancer (ZoptEC) of the compound in women with advanced, recurrent, or metastatic endometrial cancer.
Shares of Patterson-UTI Energy, Inc. (NASDAQ:PTEN), declined -2.64% to $16.25, during its last trading session. In the last trading session, the stock moved on high volume, trading at a volume of 8.76 M as compared to its average daily volume of 5.84 million shares.
The stock, as of recent close, has shown weekly upbeat performance of 23.67% which was maintained at 10.39% in 1-month period, as oil prices slump on record high U.S. stockpiles.
U.S. crude stockpiles rose by 3.1 million barrels last week to 461 million barrels in a second week of gains, according to Energy Information Administration data released on Wednesday, the Wall Street Journal reports. Analysts had estimated for an improvement of 2.5 million barrels.
The data showed total crude oil and petroleum products supplies climbed by 2.3 million barrels to 1.3 billion barrels, a record for EIA data dated back to 1990, according to the Journal.
Crude oil (WTI) is down by 1.30% to $47.90 per barrel this afternoon and Brent crude is decreasing by 0.91% to $51.45 per barrel, according to the CNBC.com index.
Patterson-UTI Energy, Inc., through its auxiliaries, provides onshore contract drilling services to major and independent oil and natural gas operators in the United States and Canada. The company operates through three segments: Contract Drilling, Pressure Pumping, and Oil and Natural Gas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
